Cite
HARVARD Citation
Scagliotti, G. et al. (2019). Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial. Lancet. 7 (7), pp. 569-580. [Online].